KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Amortization - Intangibles (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Amortization - Intangibles data on record, last reported at $21.0 million in Q4 2025.

  • For Q4 2025, Amortization - Intangibles fell 49.12% year-over-year to $21.0 million; the TTM value through Dec 2025 reached $179.1 million, up 29.34%, while the annual FY2025 figure was $179.1 million, 29.34% up from the prior year.
  • Amortization - Intangibles reached $21.0 million in Q4 2025 per CRL's latest filing, down from $27.4 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $65.4 million in Q2 2025 and bottomed at $21.0 million in Q4 2025.
  • Average Amortization - Intangibles over 5 years is $36.3 million, with a median of $34.1 million recorded in 2023.
  • The widest YoY moves for Amortization - Intangibles: up 103.11% in 2025, down 49.12% in 2025.
  • A 5-year view of Amortization - Intangibles shows it stood at $30.2 million in 2021, then increased by 17.19% to $35.4 million in 2022, then decreased by 3.99% to $34.0 million in 2023, then rose by 21.3% to $41.3 million in 2024, then plummeted by 49.12% to $21.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortization - Intangibles were $21.0 million in Q4 2025, $27.4 million in Q3 2025, and $65.4 million in Q2 2025.